311 related articles for article (PubMed ID: 18524499)
1. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Keyes KM; Martins SS; Hasin DS
Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
[TBL] [Abstract][Full Text] [Related]
2. The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.
Wu LT; Parrott AC; Ringwalt CL; Yang C; Blazer DG
Am J Addict; 2009; 18(6):452-61. PubMed ID: 19874166
[TBL] [Abstract][Full Text] [Related]
3. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
Topp L; Barker B; Degenhardt L
Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Hasin DS; Stinson FS; Ogburn E; Grant BF
Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.
Compton WM; Thomas YF; Stinson FS; Grant BF
Arch Gen Psychiatry; 2007 May; 64(5):566-76. PubMed ID: 17485608
[TBL] [Abstract][Full Text] [Related]
6. Tri-city study of Ecstasy use problems: a latent class analysis.
Scheier LM; Ben Abdallah A; Inciardi JA; Copeland J; Cottler LB
Drug Alcohol Depend; 2008 Dec; 98(3):249-63. PubMed ID: 18674872
[TBL] [Abstract][Full Text] [Related]
7. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Conway KP; Compton W; Stinson FS; Grant BF
J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
[TBL] [Abstract][Full Text] [Related]
8. Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
Daniulaityte R; Falck RS; Wang J; Carlson RG
Addict Behav; 2009 Aug; 34(8):649-53. PubMed ID: 19398164
[TBL] [Abstract][Full Text] [Related]
9. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
10. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
[TBL] [Abstract][Full Text] [Related]
11. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
12. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Martins SS; Keyes KM; Storr CL; Zhu H; Chilcoat HD
Drug Alcohol Depend; 2009 Jul; 103(1-2):16-24. PubMed ID: 19414225
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions.
Wu LT; Howard MO
Drug Alcohol Depend; 2007 May; 88(2-3):146-55. PubMed ID: 17129683
[TBL] [Abstract][Full Text] [Related]
14. 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
Martín-Santos R; Torrens M; Poudevida S; Langohr K; Cuyás E; Pacifici R; Farré M; Pichini S; de la Torre R
Addict Biol; 2010 Jan; 15(1):15-22. PubMed ID: 19878141
[TBL] [Abstract][Full Text] [Related]
15. Ecstasy use and suicidal behavior among adolescents: findings from a national survey.
Kim J; Fan B; Liu X; Kerner N; Wu P
Suicide Life Threat Behav; 2011 Aug; 41(4):435-44. PubMed ID: 21631573
[TBL] [Abstract][Full Text] [Related]
16. Mental disorders in ecstasy users: a prospective-longitudinal investigation.
Lieb R; Schuetz CG; Pfister H; von Sydow K; Wittchen H
Drug Alcohol Depend; 2002 Oct; 68(2):195-207. PubMed ID: 12234649
[TBL] [Abstract][Full Text] [Related]
17. Association of Lifetime Mental Disorders and Subsequent Alcohol and Illicit Drug Use: Results From the National Comorbidity Survey-Adolescent Supplement.
Conway KP; Swendsen J; Husky MM; He JP; Merikangas KR
J Am Acad Child Adolesc Psychiatry; 2016 Apr; 55(4):280-8. PubMed ID: 27015718
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
[TBL] [Abstract][Full Text] [Related]
19. Recent-onset ecstasy use: association with deviant behaviors and psychiatric comorbidity.
Martins SS; Mazzotti G; Chilcoat HD
Exp Clin Psychopharmacol; 2006 Aug; 14(3):275-86. PubMed ID: 16893270
[TBL] [Abstract][Full Text] [Related]
20. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
